Medlab Clinical (ASX: MDC) Share Price and News
Price
–
Movement
– ( )
(20 mins delayed)
52 Week Range
– - –
1 Year Return
Medlab Clinical Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
–
Day Change
– ( )
52 Week Range
– - –
Yesterday's Close
–
Today's Open
–
Days Range
– - –
Volume
–
Avg. Volume (1 month)
–
Turnover
–
Medlab Clinical (ASX: MDC)
Latest News
Healthcare Shares
Why is the Medlab (ASX:MDC) share price surging 8% today?
Share Market News
Here's why the Medlab (ASX:MDC) share price is rising today
Share Gainers
Why Clean TeQ, Medlab, Newcrest, & Ramelius are storming higher today
Share Gainers
Why this ASX cannabis share is shooting 15% higher today
Share Gainers
Why THC Global and these ASX cannabis shares are rocketing higher today
52-Week Highs
Why this ASX biotech is printing 52-week highs
Share Gainers
This small-cap ASX biotech's share price is soaring today
Share Gainers
Why Medlab, Metcash, SKY and Space Global, and WiseTech shares charged higher today
Share Market News
These small cap ASX shares are on the rise today
Investing
Is Medlab Clinical Ltd the best small cap healthcare buy on the ASX?
Investing
Why these pot stocks are moving higher
Investing
Why shares of Medlab Clinical Ltd have risen 37% in 2018
1❯
MDC ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|
About Medlab Clinical
Medlab Clinical Ltd. engages in the development of therapeutic pathways for diagnosed chronic diseases. It operates through the Nutraceutical Sales and Pharmaceutical Research segments. Its products include BifidoBiotic, BioClean, Biotic Jnr., GastroDaily, Lactoferrin Enhanced, Manuka-C, NanoCelle, NeuroActiv, NRGBiotic, and ORSBiotic. The company was founded by Sean Hall on June, 2012 and is headquartered in Botany, Australia.
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Tim Walker | Non-Executive Director | Mar 2012 |
Mr Walker is a corporate finance professional with experience in originating, managing, and leading resource-focused transaction. Specialising in M&A transactions across the Canadian and Australian markets, IPOs, and equity and debt financing solutions. Tim's past directorships with exploration companies have provided him with experience across commodity groups, including lithium exploration, rare earth and niobium hosted carbonatite deposits, whilst also having experience transacting on iron ore and base metal projects.
|
| Mr Edmond Tan | Non-Executive Director | Mar 2024 |
Mr Tan is a financial services professional with over 10 years' experience in roles which include Private Wealth Management, Family Office, and Structured Finance. In addition, he was involved in the establishment of a mid-market private equity joint venture fund with a focus on foreign investment into Australia. Currently, Mr Tan is a Director of Regenerate Pty Ltd a rare earth magnet recycling technology based in Houston, Texas. He is also the Australian Representative for Obsidian Global Partners LLC, a structured financier for ASX listed companies.
|
| Mr Joshua David Light | Non-Executive Director | Nov 2024 |
Mr Light is a corporate finance with broad expertise in investment banking and corporate advisory, particularly within the mining and resources sector. He has managed and facilitated numerous M&A transactions and capital raisings across primary and secondary markets in Australia and North America. Josh brings a understanding of base and critical metals and has coordinated various resource acquisitions at the junior market level.
|
| Mr Kerem Kaya | Chief Financial OfficerCompany Secretary | May 2021 |
-
|
| Kerem Kaya | Chief Financial OfficerCompany Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Mr Sean Michael Hall | 389,041 | 17.04% |
| Farjoy Pty Ltd | 205,663 | 9.01% |
| HSBC Custody Nominees (Australia) Limited | 88,229 | 3.86% |
| UBS Nominees Pty Ltd | 85,316 | 3.74% |
| Fit Investments Pty Ltd Hallab Investment A/C | 75,563 | 3.31% |
| Realm Group Pty Limited | 54,705 | 2.40% |
| Citicorp Nominees Pty Limited | 49,798 | 2.18% |
| Richard Albarran Albarran Family No 2 A/C | 37,038 | 1.62% |
| Mr Drew Anthony Townsend Townsend Family A/C | 37,038 | 1.62% |
| United Trolley Collections P/L | 32,970 | 1.44% |
| BNP Paribas Nominees Pty Ltd Ib Au Noms Retailclient | 30,272 | 1.33% |
| Mr Michael Jack Hall & Mrs Elizabeth Ann Jones Hall Jones Super Fund A/C | 29,820 | 1.31% |
| Netwealth Investments Limited Wrap Services A/C | 20,186 | 0.88% |
| Villamagna Inc | 20,000 | 0.88% |
| BNP Paribas Noms Pty Ltd | 17,164 | 0.75% |
| Daniel P Moses (Nominees) Pty Limited Daniel Moses Family A/C | 16,667 | 0.73% |
| Acron Holdings Pty Limited Acron Super Fund A/C | 16,181 | 0.71% |
| Kenney Family Investments Pty Ltd Kenney Family Account | 15,295 | 0.67% |
| Assumo (Nominees) Pty Ltd Assumo S/Fund A/C | 13,334 | 0.58% |
| D J Fairfull Pty Ltd Fairfull Super Fund A/C | 12,651 | 0.55% |